155 related articles for article (PubMed ID: 16963442)
1. Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry.
Archbold JK; Macdonald WA; Miles JJ; Brennan RM; Kjer-Nielsen L; McCluskey J; Burrows SR; Rossjohn J
J Biol Chem; 2006 Nov; 281(45):34324-32. PubMed ID: 16963442
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection.
Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558
[TBL] [Abstract][Full Text] [Related]
4. In vivo expansion of HLA-B35 alloreactive T cells sharing homologous T cell receptors: evidence for maintenance of an oligoclonally dominated allospecificity by persistent stimulation with an autologous MHC/peptide complex.
Steinle A; Reinhardt C; Jantzer P; Schendel DJ
J Exp Med; 1995 Feb; 181(2):503-13. PubMed ID: 7836907
[TBL] [Abstract][Full Text] [Related]
5. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
Burrows SR; Khanna R; Burrows JM; Moss DJ
J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
[TBL] [Abstract][Full Text] [Related]
6. T cell allorecognition via molecular mimicry.
Macdonald WA; Chen Z; Gras S; Archbold JK; Tynan FE; Clements CS; Bharadwaj M; Kjer-Nielsen L; Saunders PM; Wilce MC; Crawford F; Stadinsky B; Jackson D; Brooks AG; Purcell AW; Kappler JW; Burrows SR; Rossjohn J; McCluskey J
Immunity; 2009 Dec; 31(6):897-908. PubMed ID: 20064448
[TBL] [Abstract][Full Text] [Related]
7. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
Ueno T; Tomiyama H; Takiguchi M
J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
[TBL] [Abstract][Full Text] [Related]
8. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
[TBL] [Abstract][Full Text] [Related]
9. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules.
Shiga H; Shioda T; Tomiyama H; Takamiya Y; Oka S; Kimura S; Yamaguchi Y; Gojoubori T; Rammensee HG; Miwa K; Takiguchi M
AIDS; 1996 Sep; 10(10):1075-83. PubMed ID: 8874623
[TBL] [Abstract][Full Text] [Related]
10. The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition.
Hourigan CS; Harkiolaki M; Peterson NA; Bell JI; Jones EY; O'Callaghan CA
Eur J Immunol; 2006 Dec; 36(12):3288-93. PubMed ID: 17109469
[TBL] [Abstract][Full Text] [Related]
11. T cell can recognize the allospecificities formed by the substitution of amino acids associated with HLA-Bw4/Bw6 public epitopes.
Hiraiwa M; Yamamoto J; Matsumoto K; Karaki S; Nagao T; Kano K; Takiguchi M
Hum Immunol; 1991 Sep; 32(1):41-5. PubMed ID: 1723061
[TBL] [Abstract][Full Text] [Related]
12. T-cell allorecognition: a case of mistaken identity or déjà vu?
Archbold JK; Macdonald WA; Burrows SR; Rossjohn J; McCluskey J
Trends Immunol; 2008 May; 29(5):220-6. PubMed ID: 18378495
[TBL] [Abstract][Full Text] [Related]
13. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH
Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615
[TBL] [Abstract][Full Text] [Related]
14. Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule.
Liu YC; Miles JJ; Neller MA; Gostick E; Price DA; Purcell AW; McCluskey J; Burrows SR; Rossjohn J; Gras S
J Biol Chem; 2013 May; 288(22):15442-54. PubMed ID: 23569211
[TBL] [Abstract][Full Text] [Related]
15. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR
J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762
[TBL] [Abstract][Full Text] [Related]
16. CTL recognition of a bulged viral peptide involves biased TCR selection.
Miles JJ; Elhassen D; Borg NA; Silins SL; Tynan FE; Burrows JM; Purcell AW; Kjer-Nielsen L; Rossjohn J; Burrows SR; McCluskey J
J Immunol; 2005 Sep; 175(6):3826-34. PubMed ID: 16148129
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
[TBL] [Abstract][Full Text] [Related]
18. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.
Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA
J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027
[TBL] [Abstract][Full Text] [Related]
19. T Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ Cells.
Rist MJ; Hibbert KM; Croft NP; Smith C; Neller MA; Burrows JM; Miles JJ; Purcell AW; Rossjohn J; Gras S; Burrows SR
J Immunol; 2015 May; 194(10):4668-75. PubMed ID: 25855358
[TBL] [Abstract][Full Text] [Related]
20. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity.
Burrows SR; Kienzle N; Winterhalter A; Bharadwaj M; Altman JD; Brooks A
J Immunol; 2000 Dec; 165(11):6229-34. PubMed ID: 11086057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
